Literature DB >> 15618681

Characterization of ligand binding sites on the alpha1-acid glycoprotein in humans, bovines and dogs.

Kazuaki Matsumoto1, Katsuaki Sukimoto, Koji Nishi, Toru Maruyama, Ayaka Suenaga, Masaki Otagiri.   

Abstract

The goal of this study was to classify and identify the ligand binding sites on alpha(1)-acid glycoprotein (AGP) from 3 species, in order to understand species differences with respect to both ligand binding properties and ligand interaction on protein binding. These characteristics of human, dog and bovine AGP were examined using the basic ligands chlorpromazine and auramine O, the acidic ligand acenocoumarin, and the steroid hormone progesterone. Ultrafiltration and fluorescence techniques were used to characterize the nature of the interactions, and the data were analyzed according to the method of Kragh-Hansen. Using a model analysis of the interaction, the ligand binding site on human AGP consists of at least 3 partially overlapping subsites: a basic ligand binding site, an acidic ligand binding site and a steroid hormone binding site. Moreover, dog and bovine AGP each have a basic ligand binding site and a steroid hormone binding site, which significantly overlap and affect each other. However, dog and bovine AGPs do not contain an acidic ligand binding region. The results of the fluorescence experiments indicate that the hydrophobic nature of the ligand binding pockets on the 3 AGPs are similar, but that their microviscosities are markedly different.

Entities:  

Year:  2002        PMID: 15618681     DOI: 10.2133/dmpk.17.300

Source DB:  PubMed          Journal:  Drug Metab Pharmacokinet        ISSN: 1347-4367            Impact factor:   3.614


  11 in total

1.  On quantitative relationships between drug-like compound lipophilicity and plasma free fraction in monkey and human.

Authors:  Sami S Zoghbi; Kacey B Anderson; Kimberly J Jenko; David A Luckenbaugh; Robert B Innis; Victor W Pike
Journal:  J Pharm Sci       Date:  2011-12-13       Impact factor: 3.534

2.  Isolation, characterization and quantitation of canine alpha-1-acid glycoprotein.

Authors:  M Yuki; H Itoh; K Tamura; N Nishii; K Takase
Journal:  Vet Res Commun       Date:  2008-07-16       Impact factor: 2.459

3.  Structure-activity relationships for the binding of polymyxins with human α-1-acid glycoprotein.

Authors:  Mohammad A K Azad; Johnny X Huang; Matthew A Cooper; Kade D Roberts; Philip E Thompson; Roger L Nation; Jian Li; Tony Velkov
Journal:  Biochem Pharmacol       Date:  2012-05-12       Impact factor: 5.858

4.  Drug-binding energetics of human α-1-acid glycoprotein assessed by isothermal titration calorimetry and molecular docking simulations.

Authors:  Johnny X Huang; Matthew A Cooper; Mark A Baker; Mohammad A K Azad; Roger L Nation; Jian Li; Tony Velkov
Journal:  J Mol Recognit       Date:  2012-12       Impact factor: 2.137

5.  All-Purpose Containers? Lipid-Binding Protein - Drug Interactions.

Authors:  Tiziana Beringhelli; Elisabetta Gianazza; Daniela Maggioni; Sandra Scanu; Chiara Parravicini; Cristina Sensi; Hugo L Monaco; Ivano Eberini
Journal:  PLoS One       Date:  2015-07-13       Impact factor: 3.240

6.  Mapping a protein recognition centre with chiral photoactive ligands. An integrated approach combining photophysics, reactivity, proteomics and molecular dynamics simulation studies.

Authors:  Daniel Limones-Herrero; Raúl Pérez-Ruiz; Emilio Lence; Concepción González-Bello; Miguel A Miranda; M Consuelo Jiménez
Journal:  Chem Sci       Date:  2017-01-05       Impact factor: 9.825

7.  Canine orosomucoid (alpha-1 acid glycoprotein) variants and their influence on drug plasma protein binding.

Authors:  Ana P Costa; Michael H Court; Nicolas F Villarino; Neal S Burke; Katrina L Mealey
Journal:  J Vet Pharmacol Ther       Date:  2020-08-03       Impact factor: 1.786

8.  Molecular Characterization of Lipopolysaccharide Binding to Human α-1-Acid Glycoprotein.

Authors:  Johnny X Huang; Mohammad A K Azad; Elizabeth Yuriev; Mark A Baker; Roger L Nation; Jian Li; Matthew A Cooper; Tony Velkov
Journal:  J Lipids       Date:  2012-12-20

Review 9.  Pharmacokinetic and Pharmacodynamic Considerations for Drugs Binding to Alpha-1-Acid Glycoprotein.

Authors:  Sherri A Smith; Nigel J Waters
Journal:  Pharm Res       Date:  2018-12-28       Impact factor: 4.200

10.  Luminescence of Cypridina Luciferin in the Presence of Human Plasma Alpha 1-Acid Glycoprotein.

Authors:  Shusei Kanie; Mami Komatsu; Yasuo Mitani
Journal:  Int J Mol Sci       Date:  2020-10-12       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.